Anti-leishmanial IgE antibodies: A marker of active disease in visceral leishmaniasis

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 3, 1998, Pages 426-430

  Atta, Ajax M ^a,b   D'Oliveira Jr , Argemiro ^a   Correa, Jefferson ^a   Atta, Maria Luiza B ^a,b   Almeida, Roque P ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Depto Analises Clinicas T   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; MESSENGER RNA; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; ATOPY; CHAGAS DISEASE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN TISSUE; LEISHMANIA CHAGASI; MAJOR CLINICAL STUDY; VISCERAL LEISHMANIASIS;

EID: 0031657255     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.426     Document Type: Article

References (38)

1. Murray HW, Rubin BY, Rotermel CD, 1983. Killing of intracellular Leishmania donovani by lymphokines stimulated human mononuclear phagocytes: evidence that interferon gamma is the activating lymphokine. J Clin Invest 72: 1506-1510.
2. Carvalho EM, Bacellar O, Reed S, Barral A, Rocha H, 1988. Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill Leishmania. Braz J Med Biol Res 21: 85-92.
3. Farrel JP, Muller I, Louis JA, 1989. A role of Lyt-2 T cell in resistance to cutaneous leishmaniasis in immunized mice. J Immunol 142: 2052-2059.
4. Andrade TM, Carvalho EM, Rocha H, 1990. Bacterial infections in patients with visceral leishmaniasis. J Infect Dis 162: 1354-1359.
5. Badaró R, Carvalho EM, Orge MG, Teixeira RS, Rocha H, 1985. Imunidade humoral e celular em individuos curados de leishmaniose visceral. Rev Soc Bras Med Trop 18: 77-83.
6. Ho M, Leeuwenburg J, Mbugua G, Wamachi A, Voller A, 1983. An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 32: 943-946.
7. Andrade CR, Kirchoff LV, Donelson JE, Otsu K, 1992. Recombinant Leishmania HSP-90 and HSP-70 are recognized by sera from visceral leishmaniasis patients but not by Chagas' disease patients. J Clin Microbiol 30: 330-335.
8. Ho M, Siongok TK, Lyerly WH, Smith DK, 1982. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 76: 741-746.
9. Badaró R, Jones TC, Carvalho EM, Sampaio D, Barral A, Teixeira R, Johnson WD, 1986. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154: 1003-1011.
10. Evans TG, Teixeira MJ, McAuliffe IT, Vasconcelos IAB, Vasconcelos AW, Souza AQ, Lima JWY, Pearson RD, 1992. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 146: 1124-1132.
11. El Amin EM, Wright EP, Vlug A, 1986. Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class-and subclass-specific reagents. Clin Exp Immunol 64: 14-19.
12. Ghosh AK, Dasgupta S, Chose AC, 1995. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis. Lab Immunol 2: 291-296.
13. Carvalho EM, Barral A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H, Johnson WD, 1992. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis 165: 535-540.
14. Carvalho EK Badaró R, Reed SG, Jones TC, Johnson WD, 1985. Absence of gamma-IFN and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 76: 2066-2069.
15. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA, 1987. An analysis of T cell responsiveness in Indian kala-azar. J Immunol 138: 908-913.
16. Holaday BJ, Pompem ML, Geromino S, Teixeira MJ, Souza AQ, Vasconcelos AW, Pearson RD, Abrams JS, Locksley RM, 1993. Potential role for interleukin-10 in the immunosuppression associated with kala-azar. J Clin Invest 92: 2626-2632.
17. Karp CL, El-Safi SH, Wynn TA, Satti MNM, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB, Sacks DL, 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon gamma. J Clin Invest 91: 1644-1648.
18. Ghalib HW, Piuvezam MR, Skeiky YAW, Siddig M, Hashim FA, El-Hassan AM, Russo DM, Reed SG, 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92: 324-329.
19. Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG, 1994. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949-5956.
20. Locksley RM, Scott P, 1991. Helper T cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol Today 12: A58-A61.
21. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sendkamp B, Neiger S, 1990. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous IL-4 over IFN-gamma production. Clin Immunol Immunopathol 57: 242-249.
22. Coffman RL, Carty JA, 1986. T cell activity that enhances polyclonal IgE production and its inhibition by interferon gamma. J Exp Med 136: 949-954.
23. Yanagihara Y, Ikizawa K, Kajiwara K, Koshio T, Basaki Y, Akiyama K, 1995. Functional significance of IL-4 receptor on B cells in IL-4-induced human IgE production. J Allergy Clin Immunol 96: 1145-1151.
24. D'Oliveira A Jr, Costa SRM, Barbosa AB, Orge Orge MG, Carvalho EM, 1997. Asymptomatic L. chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz 92: 15-20.
25. Bradford MM, 1996. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein by binding. Anal Biochem 72: 248-254.
26. Laemmli UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227: 680-685.
27. Capron A, Deibbant JM, Capron M, Bazin H, 1975. Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni. Nature 233: 474-475.
28. Dessein AJ, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, Carneiro-Carvalho D, Ouattara M, Goudot-Crozel V, Dessein H, Bourgois A, Abel L, Carvalho EM, Prata A, 1992. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 21: 423-453.
29. Ahmad A, Wang CH, Bell R, 1991. Expression of rapid expulsion of Trichinella spiralis in rats transfused with IgE and thoracic duct lymphocytes. J Immunol 146: 3563-3569.
30. Dunne DW, Butterworth AE, Fulford AJC, Kariuki HC, Langley JG, Ouma JH, Capron A, Pierce RJ, Sturrock RF, 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 22: 1483-1494.
31. Wong SY, Hajdu M, Ramirez R, Thulliez P, McLeod R, Remington JS, 1993. Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J Clin Microbiol 31: 2952-2959.
32. Perlmann H, Helmby H, Hagstedt M, Carlson J, Larson PH, Troye-Blomberg M, Perlman P, 1994. IgE elevation and IgE anti malarial antibodies in Plasmodium falciparum malaria association of high IgE levels with cerebral malaria. Clin Exp Immunol 97: 284-292.
33. Vigano A, Principi N, Crupi L, Omorato J, Vincenzo ZG, Salvaggio A, 1995. Elevation of IgE in HIV infected children and its correlation with the progression of disease. J Allergy Clin Immunol 95: 627-632.
34. Galvão-Castro B, SA-Ferreira JA, Marzochi KF, Marzochi MC, Coutinho SG, Lambert PH, 1984. Polyclonal B cell activation circulating immune complexes and auto-immunity in human visceral leishmaniasis. Clin Exp Immunol 56: 727-733.
35. Chatelain R, Varkila K, Coffman RL, 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 148: 1182-1187.
36. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, Carvalho EM, 1996. Interleukin-12 restores IFN-gamma production in cytotoxic responses in visceral leishmaniasis. J Infect Dis 173: 1515-1518.
37. Badaró R, Reed S, Carvalho EM, 1983. Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg 32: 480-484.
38. Carvalho EM, Teixeira RS, Johnson WD, 1981. Cell mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 33: 498-502.